comparemela.com

Latest Breaking News On - Nektar therapeutics daily - Page 1 : comparemela.com

Howard W Robin Sells 16,650 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 16,650 shares of Nektar Therapeutics stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $1.75, for a total transaction of $29,137.50. Following the sale, the chief executive officer now directly owns 863,239 shares […]

Deep Track Capital, Lp Sells 56,000 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Deep Track Capital, Lp Sells 56,000 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Nektar Therapeutics (NASDAQ:NKTR) Announces Quarterly Earnings Results

Nektar Therapeutics (NASDAQ:NKTR) Announces Quarterly Earnings Results
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Nektar Therapeutics (NKTR) Scheduled to Post Quarterly Earnings on Thursday

Nektar Therapeutics (NKTR) Scheduled to Post Quarterly Earnings on Thursday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nektar Therapeutics (NASDAQ:NKTR) Given Average Recommendation of Hold by Brokerages

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average rating of “Hold” from the five research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.